Data gathered: October 13
Alternative Data for Scinai Immunotherapeutics
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 1,000 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 1 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 6,002 | Sign up | Sign up | Sign up |
| Twitter Mentions | 38 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
About Scinai Immunotherapeutics
None
| Price | $3.80 |
| Target Price | Sign up |
| Volume | 1,760 |
| Market Cap | $3.2M |
| Year Range | $2.69 - $5.89 |
| Dividend Yield | 0% |
| PE Ratio | 0 |
| Analyst Rating | 0% buy |
| Industry | Biotechnology |
In the news
 |
Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) Short Interest UpdateSeptember 29 - ETF Daily News |
|
Scinai Immunotherapeutics (NASDAQ:SCNI) & Mesoblast (NASDAQ:MESO) Head to Head ReviewSeptember 21 - ETF Daily News |
IBN Announces Latest Episode of The BioMedWire Podcast featuring Amir Reichman, CEO of Scinai Immunotherapeutics Ltd.September 8 - GlobeNewswire |
|
 |
Scinai to Host Online Expert Panel on Plaque Psoriasis Treatment and Intralesional Injections of anti-IL-17A/F VHH AntibodiesSeptember 15 - Yahoo |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q2 '24 | 0 | 0 | 0 | 0 | 0 | -4.310 |
| Q4 '23 | 0 | 85,000 | 19M | -3.1M | -1.7M | -4.700 |
| Q3 '23 | 3.8M | 140,000 | 3.8M | 3.8M | -2M | 0.800 |
| Q2 '23 | 0 | 1.1M | -1.1M | -3.8M | -2.6M | -1.110 |
| Q1 '23 | 0 | 1.4M | -1.4M | -3.5M | -3M | -1.090 |
Insider Transactions View All
No recorded Insider transactions.
Similar companies
Read more about Scinai Immunotherapeutics (SCNI) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, sentiment, webpage traffic, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter mentions, news mentions & customer reviews.
What is the Market Cap of Scinai Immunotherapeutics?
The Market Cap of Scinai Immunotherapeutics is $3.2M.
What is Scinai Immunotherapeutics' PE Ratio?
As of today, Scinai Immunotherapeutics' PE (Price to Earnings) ratio is 0.
What is the current stock price of Scinai Immunotherapeutics?
Currently, the price of one share of Scinai Immunotherapeutics stock is $3.80.
How can I analyze the SCNI stock price chart for investment decisions?
The SCNI stock price chart above provides a comprehensive visual representation of Scinai Immunotherapeutics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Scinai Immunotherapeutics shares. Our platform offers an up-to-date SCNI stock price chart, along with technical data analysis and alternative data insights.
Does SCNI offer dividends to its shareholders?
As of our latest update, Scinai Immunotherapeutics (SCNI) does not offer dividends to its shareholders. Investors interested in Scinai Immunotherapeutics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Scinai Immunotherapeutics?
Some of the similar stocks of Scinai Immunotherapeutics are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.